Application Information

This drug has been submitted to the FDA under the reference 204119/001.

Names and composition

"EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE" is the commercial name of a drug composed of EFAVIRENZ and LAMIVUDINE and TENOFOVIR DISOPROXIL FUMARATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
204119/001 EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 600MG and 300MG and 300MG
204568/001 EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 600MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
204119/001 EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 600MG and 300MG and 300MG
204568/001 EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE TABLET/ ORAL 600MG
205861/001 EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE TABLET/ORAL 600MG and 300MG and 300MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved